Open Access. Powered by Scholars. Published by Universities.®
- Publication Type
Articles 1 - 3 of 3
Full-Text Articles in Law
Injury-In-Fact In Chilling Effect Challenges To Public University Speech Codes, Jennifer L. Bruneau
Injury-In-Fact In Chilling Effect Challenges To Public University Speech Codes, Jennifer L. Bruneau
Catholic University Law Review
Campus speech codes began to spring up on university campuses during the 1980s and continue to operate today. The codes regulate various forms of arguably offensive speech, including speech regarding race, gender, sexual orientation, ideology, views, and political affiliation. Numerous litigants have challenged the chilling effect these policies have on student and faculty speech, but in cases where the challenged code has not yet been enforced, some courts find that the plaintiff has not met the “injury-in-fact” requirement for Article III standing. The Supreme Court has not ruled on standing requirements in speech code challenges and lower courts are divided. …
Patent Law As Public Law, Megan M. La Belle
Patent Law As Public Law, Megan M. La Belle
Scholarly Articles
Historically, patent litigation has been viewed and treated primarily as private law litigation, as opposed to public law litigation. This paradigm has begun to shift, however, as various stakeholders have come to acknowledge the profound impact that the patent system – and particularly invalid patents – have on the public at large. Yet, in order for a public law regime to succeed, there must be a host of enforcement mechanisms available, including the opportunity for privately-initiated litigation.
Public interest organizations have played a prominent role in the enforcement of certain public rights, such as free speech, equal protection, and environmental …
Standing To Sue In The Myriad Genetics Case, Megan M. La Belle
Standing To Sue In The Myriad Genetics Case, Megan M. La Belle
Scholarly Articles
In recent years, the topic of gene patents has generated significant debate among medical researchers, biotechnology companies, academics, policymakers, and patent lawyers. The controversy implicates a wide range of legal and policy questions, including whether human genes should be patentable, and whether such patents stimulate or stifle innovation. In Association for Molecular Pathology v. Myriad Genetics, a high-profile case recently before the United States Court of Appeals for the Federal Circuit, a divided panel of the court addressed these questions. Before reaching the merits of the case, however, the court had to decide whether the plaintiffs had standing to sue …